Add a listing
    Add a listing

    Underdog Pharmaceuticals

      pursuing a mission to treat the underlying causes of age-related disease

    General
    • Headquarters

      Mountain View, California, United States

    • Founders & Team

      Michael Kope, Dr. Matthew ‘Oki’ O’Connor

    • Year Founded

      2019

    • Company type

      Private company

    • Funding stage

      Seed

    • Total funding ($M)

      4

    Technical Details
    • Aging Target

      Extracellular aggregates

    • Disease indication

      atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration

    • Product modality

      small molecule

    • Clinical stage

      Pre-clinical

    About

    Underdog Pharmaceuticals, Inc., is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In